Target product profile for therapy of neonatal sepsis in high-resistance settings

Target product profile for therapy of neonatal sepsis in high-resistance settings PDF Author:
Publisher: World Health Organization
ISBN: 9240003851
Category : Medical
Languages : en
Pages : 8

Get Book Here

Book Description

Target product profile for therapy of neonatal sepsis in high-resistance settings

Target product profile for therapy of neonatal sepsis in high-resistance settings PDF Author:
Publisher: World Health Organization
ISBN: 9240003851
Category : Medical
Languages : en
Pages : 8

Get Book Here

Book Description


Target Product Profile for Therapy of Neonatal Sepsis in High Resistance Settings

Target Product Profile for Therapy of Neonatal Sepsis in High Resistance Settings PDF Author: world health organization
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

Get Book Here

Book Description


Target product profiles for needed antibacterial agents

Target product profiles for needed antibacterial agents PDF Author:
Publisher: World Health Organization
ISBN: 9240003894
Category : Medical
Languages : en
Pages : 32

Get Book Here

Book Description


Sepsis in Neonates and Children

Sepsis in Neonates and Children PDF Author: Luregn J. Schlapbach
Publisher: Frontiers Media SA
ISBN: 288966323X
Category : Medical
Languages : en
Pages : 261

Get Book Here

Book Description


Early-onset Neonatal Sepsis

Early-onset Neonatal Sepsis PDF Author: Karen D. Fairchild
Publisher:
ISBN: 9781437718553
Category : Neonatology
Languages : en
Pages : 0

Get Book Here

Book Description


Pocket Book of Hospital Care for Children

Pocket Book of Hospital Care for Children PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241548371
Category : Business & Economics
Languages : en
Pages : 442

Get Book Here

Book Description
The Pocket Book is for use by doctors nurses and other health workers who are responsible for the care of young children at the first level referral hospitals. This second edition is based on evidence from several WHO updated and published clinical guidelines. It is for use in both inpatient and outpatient care in small hospitals with basic laboratory facilities and essential medicines. In some settings these guidelines can be used in any facilities where sick children are admitted for inpatient care. The Pocket Book is one of a series of documents and tools that support the Integrated Managem.

Reducing Birth Defects

Reducing Birth Defects PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309166837
Category : Medical
Languages : en
Pages : 270

Get Book Here

Book Description
Each year more than 4 million children are born with birth defects. This book highlights the unprecedented opportunity to improve the lives of children and families in developing countries by preventing some birth defects and reducing the consequences of others. A number of developing countries with more comprehensive health care systems are making significant progress in the prevention and care of birth defects. In many other developing countries, however, policymakers have limited knowledge of the negative impact of birth defects and are largely unaware of the affordable and effective interventions available to reduce the impact of certain conditions. Reducing Birth Defects: Meeting the Challenge in the Developing World includes descriptions of successful programs and presents a plan of action to address critical gaps in the understanding, prevention, and treatment of birth defects in developing countries. This study also recommends capacity building, priority research, and institutional and global efforts to reduce the incidence and impact of birth defects in developing countries.

Oral Cephalosporins

Oral Cephalosporins PDF Author: Robert C. Moellering
Publisher: S Karger Ag
ISBN: 9783805561631
Category : Medical
Languages : en
Pages : 0

Get Book Here

Book Description
This volume provides an excellent survey of the chemistry, microbiology, pharmacology and clinical use of the oral cephalosporins in general and the newer agents in particular. The cephalosporins have long provided satisfactory treatment for many disorders without causing serious side effects; and over the past fifty years forms with different antimicrobial, pharmacologic and toxicologic properties have been developed. Despite the broad spectrum of their activity against a large variety of gram-positive and gram-negative bacteria, the third-generation oral cephalosporins including the prodrug esters do not work against Pseudomonas aeruginosa, methicillin-resistant staphylococci, enterococci or Bacteroides species. Many, however, are suitable for treating infections of the respiratory and urinary tracts and of the skin and its structure, as well as certain sexually-transmitted diseases. Authors consider other possible uses, against multi-resistant Enterobacteriaceae for instance, but also point out the limitations of the oral cephalosporins. For those working in the fields of infectious disease, bacteriology, chemotherapy, pharmaceutics and pharmacokinetics, this book is a valuable source of authoritative information.

Sepsis Management in Resource-limited Settings

Sepsis Management in Resource-limited Settings PDF Author: Arjen M. Dondorp
Publisher: Springer
ISBN: 3030031438
Category : Medical
Languages : en
Pages : 216

Get Book Here

Book Description
This book is open access under a CC BY 4.0 license. It constitutes a unique source of knowledge and guidance for all healthcare workers who care for patients with sepsis and septic shock in resource-limited settings. More than eighty percent of the worldwide deaths related to sepsis occur in resource-limited settings in low and middle-income countries. Current international sepsis guidelines cannot be implemented without adaptations towards these settings, mainly because of the difference in local resources and a different spectrum of infectious diseases causing sepsis. This prompted members of the Global Intensive Care working group of the European Society of Intensive Care Medicine (ESICM) and the Mahidol-Oxford Tropical Medicine Research Unit (MORU, Bangkok, Thailand) - among which the Editors – to develop with an international group of experts a comprehensive set of recommendations for the management of sepsis in resource-limited settings. Recommendations are based on both current scientific evidence and clinical experience of clinicians working in resource-limited settings. The book includes an overview chapter outlining the current challenges and future directions of sepsis management as well as general recommendations on the structure and organization of intensive care services in resource-limited settings. Specific recommendations on the recognition and management of patients with sepsis and septic shock in these settings are grouped into seven chapters. The book provides evidence-based practical guidance for doctors in low and middle income countries treating patients with sepsis, and highlights areas for further research and discussion.

Antimicrobial Resistance in Developing Countries

Antimicrobial Resistance in Developing Countries PDF Author: Aníbal de J. Sosa
Publisher: Springer Science & Business Media
ISBN: 0387893709
Category : Science
Languages : en
Pages : 553

Get Book Here

Book Description
Avoiding infection has always been expensive. Some human populations escaped tropical infections by migrating into cold climates but then had to procure fuel, warm clothing, durable housing, and crops from a short growing season. Waterborne infections were averted by owning your own well or supporting a community reservoir. Everyone got vaccines in rich countries, while people in others got them later if at all. Antimicrobial agents seemed at first to be an exception. They did not need to be delivered through a cold chain and to everyone, as vaccines did. They had to be given only to infected patients and often then as relatively cheap injectables or pills off a shelf for only a few days to get astonishing cures. Antimicrobials not only were better than most other innovations but also reached more of the world’s people sooner. The problem appeared later. After each new antimicrobial became widely used, genes expressing resistance to it began to emerge and spread through bacterial populations. Patients infected with bacteria expressing such resistance genes then failed treatment and remained infected or died. Growing resistance to antimicrobial agents began to take away more and more of the cures that the agents had brought.